J. GUIMARÃES ET AL. 269
primary therapeutic modality in th e treatment of selected
cases of LAOSCC and is related with a significant better
overall survival, progression-free survival and locore-
gional control rates.
5. Conclusion
According to this study, including surgery as an initial
therapeutic option in the treatment of selected cases of
LAOSCC, followed by CCRT may lead to better overall
survival, progression-free survival and locoregional con-
trol rates and an apparent lower risk of death or tumor
progression. For this reason, surgery has an important
role as a primary therapeutic choice in the treatment of
LAOSCC.
REFERENCES
[1] P. J. Bradley, “Management of Squamous Cell Carci-
noma of the Oropharynx,” Current Opinion in Otolaryn-
gology and Head and Neck Surgery, Vol. 8, No. 2, 2000,
pp. 80-86.
http://dx.doi.org/10.1097/00020840-200004000-00002
[2] M. L. Gillison, “Current Topics in the Epidemiology of
Oral Cavity and Oropharyngeal Cancers,” Head and Neck,
Vol. 29, No. 8, 2007, pp. 779-792.
http://dx.doi.org/10.1002/hed.20573
[3] Registo Oncológico Regional do Norte (RORENO).
http://www.ipoporto.pt/sobre/universo-ipo-porto/
[4] A. K. Chaturvedi, E. A. Engels, W. F. Anderson and M. L.
Gillison, “Incidence Trends for Human Papillomavirus-
Related and Unrelated Oral Squamous Cell Carcinomas
in the United States,” Journal of Clinical Oncology, Vol.
26, No. 4, 2008, pp. 612-619.
http://dx.doi.org/10.1200/JCO.2007.14.1713
[5] J. C. Wadsley and S. M. Bentzen, “Investigation of Rela-
tionship between Change in Locoregional Control and
Change in Overall Survival in Randomized Controlled
Trials of Modified Radiotherapy in Head-and-Neck Can-
cer,” International Journal of Radiation Oncology*Biology
*Physics, Vol. 60, No. 5, 2004, pp. 1405-1409.
[6] R. E. Lundahl, R. L. Foote, J. A. Bonner, V. J. Suman, J.
E. Lewis, et al., “Combined Neck Dissection and postop-
erative Radiation Therapy in the Management of the
High-Risk Neck: A Matched-Pair Analysis,” Interna-
tional Journal of Radiation Oncology*Biology*Physics,
Vol. 40, No. 3, 1998, pp. 529-534.
[7] U. Duvvuri and J. N. Myers, “Contemporary Manage-
ment of Oropharyngeal Cancer: Anatomy and Physiology
of the Oropharynx,” Current Problems in Surgery, Vol.
46, No. 2, 2009, pp. 119-184.
http://dx.doi.org/10.1067/j.cpsurg.2008.10.003
[8] J. M. Bumpous, “Surgical Salvage of Cancer of the Oro-
pharynx after Chemoradiation,” Current Oncology Re-
ports, Vol. 11, No. 2, 2009, pp. 151-155.
http://dx.doi.org/10.1007/s11912-009-0022-6
[9] J. T. Parsons, W. M. Mendenhall, S. P. Stringer, R. J.
Amdur, R. W. Hinerman, et al., “Squamous Cell Carci-
noma of the Oropharynx Surgery, Radiation Therapy, or
Both,” Cancer, Vol. 26, No. 11, 2002, pp. 612-619.
[10] D. A. Fein, W. R. Lee, W. R. Amos, R. W. Hinerman, J.
T. Parsons, et al., “Oropharyngeal Carcinoma Treated
with Radiotherapy: A 30-Year Experience,” International
Journal of Radiation Oncology*Biology*Physics, Vol. 34,
No. 2, 1996, pp. 289-296.
[11] J. P. Bataini, B. Asselain, C. Jaulerry, F. Burnin, J.
Bernier, et al., “A Multivariate Primary Tumour Control
Analysis in 465 Patients Treated by Radical Radiotherapy
for Cancer of the Tonsillar Region: Clinical and Treat-
ment Parameters as Prognostic Factors,” Radiotherapy &
Oncology, Vol. 14, No. 4, 1989, pp. 265-277.
http://dx.doi.org/10.1016/0167-8140(89)90138-2
[12] G. Calais, M. Alfonsi, E. Bardet, C. Sire, T. Germain, et
al., “Randomized Trial of Radiation Therapy versus
Concomitante Chemotherapy and Radiation Therapy for
Advanced-Stage Oropharyngeal Carcinoma,” Journal of
the National Cancer Institute, Vol. 91, No. 24, 1999, pp.
2081-2086. http://dx.doi.org/10.1093/jnci/91.24.2081
[13] D. J. Adelstein, P. Lavertu, J. P. Saxton, M. Secic, B. J.
Wood, et al., “Mature Results of a Phase III Randomized
trial Comparing Concurrent Chemoradiotherapy with Ra-
diation Therapy Alone in Patients with Stage III and IV
Squamous Cell Carcinoma of the Head and Neck,” Can-
cer, Vol. 88, No. 4, 2000, pp. 876-883.
http://dx.doi.org/10.1002/(SICI)1097-0142(20000215)88:
4<876::AID-CNCR19>3.0.CO;2-Y
[14] K. C. Soo, E. H. Tan, J. Wee, B. Lim, D. C. Tai, et al.,
“Surgery and Adjuvant Radiotherapy vs. Concurrent Che-
moradiotherapy in Stage III/IV Nonmetastatic Squamous
Cell Head and Neck Cancer: A Randomized Compari-
son,” British Journal of Cancer, Vol. 93, No. 3, 2005, pp.
279-286. http://dx.doi.org/10.1038/sj.bjc.6602696
[15] P. Boscolo-Rizzo, A. Gava, V. Baggio, C. Marchiori, M.
Stellin, et al., “Matched Survival Analysis in Patients
with Locoregionally Advanced Resectable Oropharyngeal
Carcinoma: Platinum-Based Induction and Concurrent
Chemoradiotherapy versus Primary Surgical Resection,”
International Journal of Radiation Oncology*Biology*
Physics, Vol. 80, No. 1, 2011, pp. 154-160.
[16] J. L. Lefebvre, D. Chevalier, B. Luboinski, A. Kirkpatrick,
L. Collette and T. Sahmoud, and for the EORTC Head
and Neck Cancer Cooperative Group, “Larynx Preserva-
tion in Pyriform Sinus Cancer: Preliminary Results of a
European Organization for Research and Treatment of
Cancer Phase III Trial,” Journal of the National Cancer
Institute, Vol. 88, No. 13, 1996, pp. 890-899.
http://dx.doi.org/10.1093/jnci/88.13.890
[17] A. Argiris, B. E. Brockstein, D. J. Haraf , K. M. Stenson,
B. B. Mittal, et al., “Competing Causes of Death and
Second Primary Tumors in Patients with Locoregionally
Advanced Head and Neck Cancer Treated with Chemora-
diotherapy,” Clinical Cancer Research, Vol. 10, No. 6,
2004, pp. 1956-1962.
http://dx.doi.org/10.1158/1078-0432.CCR-03-1077
[18] C. Fakhry, W. H. Westra, S. Li, A. Cmelak, J. A. Ridge,
et al., “Improved Survival of Patients with Human Papil-
lomavirus-Positive Head and Neck Squamous Cell Car-
cinoma in a Prospective Clinical Trial,” Journal of the
Open Access IJOHNS